These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Pharmacokinetic and pharmacodynamic drug interactions with Kava (Piper methysticum Forst. f.). Anke J; Ramzan I J Ethnopharmacol; 2004 Aug; 93(2-3):153-60. PubMed ID: 15234747 [TBL] [Abstract][Full Text] [Related]
5. Health policy versus kava (Piper methysticum): Anxiolytic efficacy may be instrumental in restoring the reputation of a major South Pacific crop. Thomsen M; Schmidt M J Ethnopharmacol; 2021 Mar; 268():113582. PubMed ID: 33189846 [TBL] [Abstract][Full Text] [Related]
6. Composition and biological activity of traditional and commercial kava extracts. Côté CS; Kor C; Cohen J; Auclair K Biochem Biophys Res Commun; 2004 Sep; 322(1):147-52. PubMed ID: 15313185 [TBL] [Abstract][Full Text] [Related]
8. Investigating volatiles as the secondary metabolome of Piper methysticum from root powder and water extracts using comprehensive two-dimensional gas chromatography. Cheung C; Baker JD; Byrne JM; Perrault KA J Ethnopharmacol; 2022 Aug; 294():115346. PubMed ID: 35533912 [TBL] [Abstract][Full Text] [Related]
9. Quantitative elimination of Flavokavines A and B from Kava Kava (Piper methysticum G. Forst) by isoelectric focused adsorptive bubble separation. Backleh M; Ekici P; Leupold G; Parlar H Naturwissenschaften; 2003 Aug; 90(8):366-9. PubMed ID: 12955226 [TBL] [Abstract][Full Text] [Related]
10. Kava Hepatotoxicity: Are we any closer to the truth? Anke J; Ramzan I Planta Med; 2004 Mar; 70(3):193-6. PubMed ID: 15114493 [TBL] [Abstract][Full Text] [Related]
15. Identification by methane chemical ionization gas chromatography/mass spectrometry of the products obtained by steam distillation and aqueous acid extraction of commercial Piper methysticum. Cheng D; Lidgard RO; Duffield PH; Duffield AM; Brophy JJ Biomed Environ Mass Spectrom; 1988 Nov; 17(5):371-6. PubMed ID: 3207926 [TBL] [Abstract][Full Text] [Related]
16. Interaction of various Piper methysticum cultivars with CNS receptors in vitro. Dinh LD; Simmen U; Bueter KB; Bueter B; Lundstrom K; Schaffner W Planta Med; 2001 Jun; 67(4):306-11. PubMed ID: 11458444 [TBL] [Abstract][Full Text] [Related]
17. Determination of kavalactones in dried kava (Piper methysticum) powder using near-infrared reflectance spectroscopy and partial least-squares regression. Gautz LD; Kaufusi P; Jackson MC; Bittenbender HC; Tang CS J Agric Food Chem; 2006 Aug; 54(17):6147-52. PubMed ID: 16910700 [TBL] [Abstract][Full Text] [Related]
18. [A drug from Polynesia with central nervous activity: Piper methysticum Forst ("kawa-kawa")]. REALDON E Gazz Med Ital; 1960 Jun; 119():231-3. PubMed ID: 14436715 [No Abstract] [Full Text] [Related]
19. Synthesis, in vitro, reactivity, and identification of 6-phenyl-3-hexen-2-one in human urine after kava-kava (Piper methysticum) ingestion. Zou L; Harkey MR; Henderson GL Planta Med; 2005 Feb; 71(2):142-6. PubMed ID: 15729622 [TBL] [Abstract][Full Text] [Related]
20. The impact of traditional kava (Piper methysticum) use on cognition: Implications for driver fitness. Aporosa S'; Ballard H; Pandey R; McCarthy MJ J Ethnopharmacol; 2022 Jun; 291():115080. PubMed ID: 35151837 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]